Pleiotropic effects of fenofibrate therapy on rats with hypertriglycemia.

Item

http://www.wikidata.org/entity/Q39908570

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Pleiotropic effects of fenofibrate therapy on rats with hypertriglycemia.

@en

Pleiotropic effects of fenofibrate therapy on rats with hypertriglycemia.

@nl

type

Item

label

Pleiotropic effects of fenofibrate therapy on rats with hypertriglycemia.

@en

Pleiotropic effects of fenofibrate therapy on rats with hypertriglycemia.

@nl

prefLabel

Pleiotropic effects of fenofibrate therapy on rats with hypertriglycemia.

@en

Pleiotropic effects of fenofibrate therapy on rats with hypertriglycemia.

@nl

P1476

Pleiotropic effects of fenofibrate therapy on rats with hypertriglycemia.

@en

P2093

Bing Sun

http://www.w3.org/2001/XMLSchema#string

Cuimei Zhao

http://www.w3.org/2001/XMLSchema#string

Feifei Huang

http://www.w3.org/2001/XMLSchema#string

Jinfa Jiang

http://www.w3.org/2001/XMLSchema#string

Xiaolin Xu

http://www.w3.org/2001/XMLSchema#string

Yiping Wang

http://www.w3.org/2001/XMLSchema#string

Yuan Xie

http://www.w3.org/2001/XMLSchema#string

P2860

Intensive lowering of LDL cholesterol with 80 mg versus 20 mg simvastatin daily in 12,064 survivors of myocardial infarction: a double-blind randomised trial

2013 ACC/AHA guideline recommends fixed-dose strategies instead of targeted goals to lower blood cholesterol.

2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines

Loss-of-function mutations in APOC3, triglycerides, and coronary disease

Preferential reduction of very low density lipoprotein-1 particle number by fenofibrate in type IIB hyperlipidemia: consequences for lipid accumulation in human monocyte-derived macrophages.

Effects of combination lipid therapy in type 2 diabetes mellitus.

Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management

The polygenic nature of hypertriglyceridaemia: implications for definition, diagnosis, and management.

Loss-of-function mutations in APOC3 and risk of ischemic vascular disease.

Hypertriglyceridemia: a too long unfairly neglected major cardiovascular risk factor.

P2888

s12944-015-0032-3

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12944-015-0032-3

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-04-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

275101241

http://www.w3.org/2001/XMLSchema#string

P6179

1041043469

http://www.w3.org/2001/XMLSchema#string

P698

25890112

http://www.w3.org/2001/XMLSchema#string

P932

4407877

http://www.w3.org/2001/XMLSchema#string